Dudum Andrew 的 Form 4/A 修正申報
修正Hims & Hers Health, Inc.（HIMS），2023/3/17 申報
- 申報編號
- 0001773751-23-000098
- 申報時間
- 2023/3/17
- 交易日
- 2023/3/1
- 申報延遲
- 16 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2023/3/3
這份申報列了 2 筆非衍生性交易、3 筆衍生性交易。公開市場賣出合計 $43.8 萬。交易後 16 天申報。
這份修正申報取代了 0001773751-23-000043（2023/3/3 申報）。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Dudum AndrewCIK 0001837796 | 董事、高階主管（執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/3/1 | Class A Common Stock | M行使選擇權取得 | +36,633 | $2.43 | +$89,018.19 | 387,248 | 直接 | |
| 2023/3/1 | Class A Common Stock | S賣出處分 | −36,633 | $11.95F2 | −$437,764.35 | 350,615 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2023/3/1 | Class A Common Stock | M行使選擇權處分 | −36,633 | $0.00 | $0 | 3,209,506 | 直接 | |
| 2023/3/1 | Class A Common Stock | A公司授予取得 | +567,144 | $0.00 | $0 | 567,144 | 直接 | |
| 2023/3/1 | Class A Common Stock | A公司授予取得 | +214,461 | $0.00 | $0 | 214,461 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2022 by the Reporting Person.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.95 - $12.02. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
- F4
The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023.
- F5
The exercise price of the options awarded has been adjusted from the original filing due to administrative error.
- F6
The options are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 1/48th of the options vesting monthly, beginning on April 1, 2023.